Altamira Therapeutics (CYTO) Provides Investor and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Altamira Therapeutics Provides Investor and Business Update
December 11, 2023 8:00 AM ESTHAMILTON, BERMUDA, Dec. 11, 2023 (GLOBE NEWSWIRE) --
Company hosts Investor and Business Update call on December 11 at 8:30 a.m. ETPartial spin-off of Bentrio® business first step in transition to become pure play RNA delivery companyTransition expected to complete in 2024 through partnering of further legacy assetsSpending levels and cash burn aligned with strategic repositioning and to decrease significantly in 2024  Free of financial debt following early repayment of convertible loan  Expects to regain full compliance with Nasdaq continued listing rules through reverse splitHAMILTON, BERMUDA, Dec. 11, 2023 --... More



